FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 102.88 Million USD | 4.3% |
| 2023 | 98.64 Million USD | 1.08% |
| 2022 | 97.59 Million USD | 8.52% |
| 2021 | 89.92 Million USD | 4.95% |
| 2020 | 85.69 Million USD | -1.72% |
| 2019 | 87.19 Million USD | 6.96% |
| 2018 | 81.51 Million USD | 4.46% |
| 2017 | 78.03 Million USD | 6.36% |
| 2016 | 73.36 Million USD | 6.25% |
| 2015 | 69.05 Million USD | 0.8% |
| 2014 | 68.5 Million USD | 39.4% |
| 2013 | 49.14 Million USD | 24.58% |
| 2012 | 39.44 Million USD | 19.04% |
| 2011 | 33.13 Million USD | 4.15% |
| 2010 | 31.81 Million USD | -19.91% |
| 2009 | 39.72 Million USD | 11.68% |
| 2008 | 35.56 Million USD | 7.1% |
| 2007 | 33.21 Million USD | 0.41% |
| 2006 | 33.07 Million USD | -68.47% |
| 2005 | 104.89 Million USD | 46.49% |
| 2004 | 71.6 Million USD | 35.39% |
| 2003 | 52.89 Million USD | 18.38% |
| 2002 | 44.67 Million USD | -3.83% |
| 2001 | 46.45 Million USD | 18.9% |
| 2000 | 39.07 Million USD | 5.89% |
| 1999 | 36.9 Million USD | 33.7% |
| 1998 | 27.6 Million USD | 56.82% |
| 1997 | 17.6 Million USD | 34.35% |
| 1996 | 13.1 Million USD | -7.09% |
| 1995 | 14.1 Million USD | -8.44% |
| 1994 | 15.4 Million USD | -8.33% |
| 1993 | 16.8 Million USD | -14.72% |
| 1992 | 19.7 Million USD | -3.9% |
| 1991 | 20.5 Million USD | -38.44% |
| 1990 | 33.3 Million USD | -27.45% |
| 1989 | 45.9 Million USD | -22.07% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 25.71 Million USD | 1.31% |
| 2024 Q2 | 25.38 Million USD | 1154.87% |
| 2024 Q1 | 2.02 Million USD | -92.15% |
| 2024 Q4 | 25.94 Million USD | 0.88% |
| 2023 Q4 | 25.77 Million USD | 1.39% |
| 2023 FY | 98.64 Million USD | 1.08% |
| 2023 Q1 | 23.19 Million USD | -6.53% |
| 2023 Q2 | 24.25 Million USD | 4.59% |
| 2023 Q3 | 25.42 Million USD | 4.81% |
| 2022 FY | 97.59 Million USD | 8.52% |
| 2022 Q1 | 23.73 Million USD | -3.91% |
| 2022 Q4 | 24.81 Million USD | 0.98% |
| 2022 Q3 | 24.57 Million USD | 0.38% |
| 2022 Q2 | 24.47 Million USD | 3.16% |
| 2021 Q3 | 23.09 Million USD | 9.1% |
| 2021 FY | 89.92 Million USD | 4.95% |
| 2021 Q1 | 20.97 Million USD | 0.83% |
| 2021 Q2 | 21.16 Million USD | 0.88% |
| 2021 Q4 | 24.69 Million USD | 6.95% |
| 2020 Q4 | 20.8 Million USD | -4.06% |
| 2020 FY | 85.69 Million USD | -1.72% |
| 2020 Q1 | 21.74 Million USD | -3.28% |
| 2020 Q2 | 21.45 Million USD | -1.36% |
| 2020 Q3 | 21.68 Million USD | 1.1% |
| 2019 FY | 87.19 Million USD | 6.96% |
| 2019 Q1 | 20.7 Million USD | -1.57% |
| 2019 Q3 | 22.77 Million USD | 7.32% |
| 2019 Q4 | 22.48 Million USD | -1.3% |
| 2019 Q2 | 21.22 Million USD | 2.51% |
| 2018 Q3 | 20.97 Million USD | 4.02% |
| 2018 Q2 | 20.16 Million USD | 4.31% |
| 2018 FY | 81.51 Million USD | 4.46% |
| 2018 Q4 | 21.03 Million USD | 0.27% |
| 2018 Q1 | 19.33 Million USD | -7.45% |
| 2017 Q4 | 20.89 Million USD | 4.41% |
| 2017 FY | 78.03 Million USD | 6.36% |
| 2017 Q1 | 18.73 Million USD | -0.19% |
| 2017 Q2 | 18.4 Million USD | -1.77% |
| 2017 Q3 | 20 Million USD | 8.72% |
| 2016 Q3 | 18.61 Million USD | 1.36% |
| 2016 Q4 | 18.76 Million USD | 0.81% |
| 2016 Q1 | 17.61 Million USD | 4.34% |
| 2016 Q2 | 18.36 Million USD | 4.3% |
| 2016 FY | 73.36 Million USD | 6.25% |
| 2015 Q3 | 17.09 Million USD | 0.02% |
| 2015 Q4 | 16.87 Million USD | -1.28% |
| 2015 FY | 69.05 Million USD | 0.8% |
| 2015 Q2 | 17.09 Million USD | -4.97% |
| 2015 Q1 | 17.98 Million USD | 5.64% |
| 2014 FY | 68.5 Million USD | 39.4% |
| 2014 Q1 | 16.83 Million USD | -8.41% |
| 2014 Q2 | 17.6 Million USD | 4.62% |
| 2014 Q3 | 17.04 Million USD | -3.23% |
| 2014 Q4 | 17.02 Million USD | -0.09% |
| 2013 Q1 | 9.51 Million USD | -13.48% |
| 2013 Q4 | 18.37 Million USD | 57.84% |
| 2013 Q3 | 11.64 Million USD | 21.11% |
| 2013 Q2 | 9.61 Million USD | 1.07% |
| 2013 FY | 49.14 Million USD | 24.58% |
| 2012 Q3 | 9.51 Million USD | 2.02% |
| 2012 Q2 | 9.32 Million USD | -2.91% |
| 2012 Q1 | 9.6 Million USD | 23.52% |
| 2012 FY | 39.44 Million USD | 19.04% |
| 2012 Q4 | 10.99 Million USD | 15.52% |
| 2011 Q3 | 8.65 Million USD | 7.92% |
| 2011 Q4 | 7.77 Million USD | -10.12% |
| 2011 Q2 | 8.01 Million USD | -7.67% |
| 2011 FY | 33.13 Million USD | 4.15% |
| 2011 Q1 | 8.68 Million USD | 1.01% |
| 2010 Q2 | 8.21 Million USD | 9.64% |
| 2010 Q1 | 7.49 Million USD | -27.91% |
| 2010 FY | 31.81 Million USD | -19.91% |
| 2010 Q4 | 8.59 Million USD | 14.43% |
| 2010 Q3 | 7.51 Million USD | -8.51% |
| 2009 Q4 | 10.39 Million USD | -7.68% |
| 2009 Q2 | 11.29 Million USD | 66.42% |
| 2009 Q3 | 11.25 Million USD | -0.3% |
| 2009 Q1 | 6.78 Million USD | -16.74% |
| 2009 FY | 39.72 Million USD | 11.68% |
| 2008 Q4 | 8.14 Million USD | 0.95% |
| 2008 FY | 35.56 Million USD | 7.1% |
| 2008 Q2 | 10.68 Million USD | 23.2% |
| 2008 Q1 | 8.66 Million USD | -3.41% |
| 2008 Q3 | 8.07 Million USD | -24.43% |
| 2007 FY | 33.21 Million USD | 0.41% |
| 2007 Q4 | 8.97 Million USD | 2.2% |
| 2007 Q3 | 8.78 Million USD | 14.47% |
| 2007 Q2 | 7.67 Million USD | -1.43% |
| 2007 Q1 | 7.78 Million USD | 19.62% |
| 2006 FY | 33.07 Million USD | -68.47% |
| 2006 Q4 | 6.5 Million USD | -8.4% |
| 2006 Q3 | 7.1 Million USD | -32.62% |
| 2006 Q2 | 10.54 Million USD | 3.82% |
| 2006 Q1 | 10.15 Million USD | -59.39% |
| 2005 Q2 | 29.49 Million USD | 17.68% |
| 2005 FY | 104.89 Million USD | 46.49% |
| 2005 Q4 | 25 Million USD | -1.3% |
| 2005 Q1 | 25.06 Million USD | 19.0% |
| 2005 Q3 | 25.33 Million USD | -14.13% |
| 2004 Q4 | 21.06 Million USD | 8.85% |
| 2004 Q1 | 13.3 Million USD | -4.2% |
| 2004 Q2 | 17.88 Million USD | 34.48% |
| 2004 Q3 | 19.35 Million USD | 8.18% |
| 2004 FY | 71.6 Million USD | 35.39% |
| 2003 Q4 | 13.88 Million USD | 42.05% |
| 2003 FY | 52.89 Million USD | 18.38% |
| 2003 Q2 | 16.34 Million USD | 19.7% |
| 2003 Q3 | 9.77 Million USD | -40.21% |
| 2003 Q1 | 13.65 Million USD | -1.08% |
| 2002 Q2 | 9.76 Million USD | -3.81% |
| 2002 FY | 44.67 Million USD | -3.83% |
| 2002 Q4 | 13.8 Million USD | 26.05% |
| 2002 Q3 | 10.95 Million USD | 12.15% |
| 2002 Q1 | 10.15 Million USD | -17.19% |
| 2001 FY | 46.45 Million USD | 18.9% |
| 2001 Q1 | 10.11 Million USD | 0.35% |
| 2001 Q4 | 12.26 Million USD | -6.46% |
| 2001 Q3 | 13.1 Million USD | 19.35% |
| 2001 Q2 | 10.98 Million USD | 8.61% |
| 2000 Q3 | 9.85 Million USD | 3.68% |
| 2000 Q4 | 10.07 Million USD | 2.29% |
| 2000 FY | 39.07 Million USD | 5.89% |
| 2000 Q1 | 9.6 Million USD | -9.43% |
| 2000 Q2 | 9.5 Million USD | -1.04% |
| 1999 Q2 | 9.1 Million USD | 21.33% |
| 1999 Q3 | 9.6 Million USD | 5.49% |
| 1999 Q4 | 10.6 Million USD | 10.42% |
| 1999 Q1 | 7.5 Million USD | 8.7% |
| 1999 FY | 36.9 Million USD | 33.7% |
| 1998 FY | 27.6 Million USD | 56.82% |
| 1998 Q4 | 6.9 Million USD | -2.82% |
| 1998 Q2 | 6.8 Million USD | 1.49% |
| 1998 Q3 | 7.1 Million USD | 4.41% |
| 1998 Q1 | 6.7 Million USD | -29.47% |
| 1997 Q3 | 2.6 Million USD | -13.33% |
| 1997 Q1 | 2.6 Million USD | 30.0% |
| 1997 FY | 17.6 Million USD | 34.35% |
| 1997 Q4 | 9.5 Million USD | 265.38% |
| 1997 Q2 | 3 Million USD | 15.38% |
| 1996 Q2 | 3.7 Million USD | -13.95% |
| 1996 Q4 | 2 Million USD | -33.33% |
| 1996 FY | 13.1 Million USD | -7.09% |
| 1996 Q1 | 4.3 Million USD | 86.96% |
| 1996 Q3 | 3 Million USD | -18.92% |
| 1995 Q2 | 3.7 Million USD | -24.49% |
| 1995 FY | 14.1 Million USD | -8.44% |
| 1995 Q1 | 4.9 Million USD | 36.11% |
| 1995 Q4 | 2.3 Million USD | -28.13% |
| 1995 Q3 | 3.2 Million USD | -13.51% |
| 1994 Q4 | 3.6 Million USD | -28.0% |
| 1994 FY | 15.4 Million USD | -8.33% |
| 1994 Q3 | 5 Million USD | 38.89% |
| 1994 Q2 | 3.6 Million USD | 12.5% |
| 1994 Q1 | 3.2 Million USD | -13.51% |
| 1993 FY | 16.8 Million USD | -14.72% |
| 1993 Q4 | 3.7 Million USD | -22.92% |
| 1993 Q2 | 4.8 Million USD | 37.14% |
| 1993 Q3 | 4.8 Million USD | 0.0% |
| 1993 Q1 | 3.5 Million USD | -25.53% |
| 1992 FY | 19.7 Million USD | -3.9% |
| 1992 Q1 | 6.1 Million USD | 15.09% |
| 1992 Q2 | 4.4 Million USD | -27.87% |
| 1992 Q3 | 4.5 Million USD | 2.27% |
| 1992 Q4 | 4.7 Million USD | 4.44% |
| 1991 Q2 | 5.4 Million USD | 5.88% |
| 1991 Q1 | 5.1 Million USD | -38.55% |
| 1991 Q4 | 5.3 Million USD | 12.77% |
| 1991 FY | 20.5 Million USD | -38.44% |
| 1991 Q3 | 4.7 Million USD | -12.96% |
| 1990 FY | 33.3 Million USD | -27.45% |
| 1990 Q1 | 8.3 Million USD | -27.83% |
| 1990 Q2 | 8.3 Million USD | 0.0% |
| 1990 Q3 | 8.3 Million USD | 0.0% |
| 1990 Q4 | 8.3 Million USD | 0.0% |
| 1989 Q2 | 11.5 Million USD | 0.0% |
| 1989 Q1 | 11.5 Million USD | 0.0% |
| 1989 FY | 45.9 Million USD | -22.07% |
| 1989 Q4 | 11.5 Million USD | 0.0% |
| 1989 Q3 | 11.5 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -753.173% |
| BrainsWay Ltd. | 31.78 Million USD | -223.688% |
| Cerus Corporation | 156.36 Million USD | 34.203% |
| Envoy Medical, Inc. | 316 Thousand USD | -32458.256% |
| electroCore, Inc. | 16.03 Million USD | -541.822% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -15875.79% |
| IceCure Medical Ltd | 3.22 Million USD | -3086.252% |
| Inogen, Inc. | 315.66 Million USD | 67.407% |
| OrthoPediatrics Corp. | 148.73 Million USD | 30.826% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -4137.401% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -28087.499% |
| MaxCyte, Inc. | 41.28 Million USD | -149.186% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -5169.511% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -92799.275% |
| Orthofix Medical Inc. | 746.64 Million USD | 86.22% |
| PAVmed Inc | 2.45 Million USD | -4095.925% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -356.877% |
| RxSight, Inc. | 89.07 Million USD | -15.5% |
| Sight Sciences, Inc. | 81.05 Million USD | -26.93% |
| SI-BONE, Inc. | 138.88 Million USD | 25.922% |
| TELA Bio, Inc. | 58.45 Million USD | -76.012% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 45.016% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -645.483% |
| Acutus Medical, Inc. | 7.16 Million USD | -1336.126% |
| Talis Biomedical Corporation | 412 Thousand USD | -24871.866% |
| Spectral AI, Inc. | 18.05 Million USD | -469.806% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -938.709% |
| CVRx, Inc. | 39.29 Million USD | -161.825% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -10520.775% |
| Bioventus Inc. | 512.34 Million USD | 79.919% |
| Venus Concept Inc. | 76.35 Million USD | -34.746% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -455.8% |
| LivaNova PLC | 1.15 Billion USD | 91.081% |
| 908 Devices Inc. | 50.22 Million USD | -104.83% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 78.666% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -133439.392% |
| NeuroPace, Inc. | 65.42 Million USD | -57.265% |
| LENSAR, Inc. | 42.16 Million USD | -144.009% |
| Apyx Medical Corporation | 52.34 Million USD | -96.535% |
| Cutera, Inc. | 212.36 Million USD | 51.554% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -208.424% |
| BioSig Technologies, Inc. | 18 Thousand USD | -571478.272% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 38.268% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -329.489% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 93.326% |
| Axonics, Inc. | 366.37 Million USD | 71.919% |
| Outset Medical, Inc. | 130.37 Million USD | 21.087% |
| IRIDEX Corporation | 51.86 Million USD | -98.354% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 24.456% |
| IRadimed Corporation | 65.56 Million USD | -56.926% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -8648.647% |
| INVO Bioscience, Inc. | 3.02 Million USD | -3306.109% |
| Telesis Bio, Inc. | 27.5 Million USD | -274.002% |
| Viemed Healthcare, Inc. | 183 Million USD | 43.782% |
| Varex Imaging Corporation | 811 Million USD | 87.314% |
| Quipt Home Medical Corp. | 221.74 Million USD | 53.602% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -49.813% |
| Dynatronics Corporation | 32.53 Million USD | -216.236% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -1085.574% |
| Semler Scientific, Inc. | 68.18 Million USD | -50.892% |
| InMode Ltd. | 492.04 Million USD | 79.091% |
| Bruker Corporation | 2.96 Billion USD | 96.529% |
| Cytosorbents Corporation | 36.34 Million USD | -183.042% |
| DexCom, Inc. | 3.62 Billion USD | 97.16% |
| Align Technology, Inc. | 3.86 Billion USD | 97.336% |
| Viveve Medical, Inc. | 6.42 Million USD | -1501.06% |
| ZimVie Inc. | 457.43 Million USD | 77.508% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 46.696% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -92799.275% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 86.24% |
| Profound Medical Corp. | 7.33 Million USD | -1303.407% |
| Insulet Corporation | 1.69 Billion USD | 93.938% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 18.396% |
| iCAD, Inc. | 17.31 Million USD | -494.088% |
| Nuwellis, Inc. | 8.86 Million USD | -1060.696% |
| Biotricity, Inc. | 12.06 Million USD | -752.865% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 79.118% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -1558.084% |
| PAVmed Inc. | 2.45 Million USD | -4095.925% |
| BIOLASE, Inc. | 49.16 Million USD | -109.267% |
| Beyond Air, Inc. | 1.15 Million USD | -8776.971% |
| AxoGen, Inc. | 159.01 Million USD | 35.298% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 62.509% |
| Inari Medical, Inc. | 493.63 Million USD | 79.158% |
| UFP Technologies, Inc. | 400.07 Million USD | 74.284% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -553040.263% |
| Tenon Medical, Inc. | 2.92 Million USD | -3413.801% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -1410.328% |
| AdaptHealth Corp. | 3.2 Billion USD | 96.785% |
| Sintx Technologies, Inc. | 2.62 Million USD | -3816.41% |
| NanoVibronix, Inc. | 2.28 Million USD | -4406.53% |
| Quanterix Corporation | 122.36 Million USD | 15.922% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -321.57% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 48.692% |
| TransMedics Group, Inc. | 241.62 Million USD | 57.42% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -642.631% |
| NeuroMetrix, Inc. | 5.9 Million USD | -1643.377% |
| Hyperfine, Inc. | 11.03 Million USD | -832.597% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 37.703% |
| Biomerica, Inc. | 5.41 Million USD | -1799.983% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -103.485% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 41.917% |